首页> 外国专利> The sustained-release (firm join Characteristic) dopamine as a cocaine, an amphetamine and a huenshikurijin antagonist, serotonin or noruepinehurin re-taking inhibiter

The sustained-release (firm join Characteristic) dopamine as a cocaine, an amphetamine and a huenshikurijin antagonist, serotonin or noruepinehurin re-taking inhibiter

机译:作为可卡因,安非他明和huenshikurijin拮抗剂,5-羟色胺或去甲肾上腺素再摄取抑制剂的多巴胺缓释(牢固结合)

摘要

Methods are disclosed for treating cocaine addiction, acute effects of cocaine, and cocaine craving in mammals using a cocaine antagonist of general formula (I). The methods of treatment can counteract cocaine intoxication and prevent relapse into drug use during and after treatment. Preferably, (1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-[3-phenylpropyl]-piperizine is administered in the range of 0.1 mg to 100 mg per kg body weight per day.
机译:公开了使用通式(I)的可卡因拮抗剂在哺乳动物中治疗可卡因成瘾,可卡因的急性作用和对可卡因的渴望的方法。治疗方法可以抵消可卡因中毒,并防止在治疗期间和治疗后复发为药物使用。优选地,以每公斤体重每天0.1mg至100mg的范围施用(1- [2- [双(4-氟苯基)-甲氧基]乙基] -4- [3-苯基丙基]-哌嗪。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号